Record · verywellhealth.com
How HER2-Negative Breast Cancer Is Treated
verywellhealth.com · 18 September 2026 · 9 min read
A post on verywellhealth.com, published 18 September 2026, has not been cited by any blog yet (corpus.blog, measured 11 October 2026).
A record is what was published and who pointed at it. The text of the post is not shown here: read it at the source, or at its Wayback capture.
0blogs citing
| Period | Blogs | Links |
|---|---|---|
| All time | 0 | 0 |
| Last 90 days | 0 | 0 |
| Last 30 days | 0 | 0 |
| Last 7 days | 0 | 0 |
| Words blogs link it with | 0 |
|---|---|
| External links | 0 |
| Length | 1,916 |
Cited by
No blog we hold has cited this post yet.
Links from this post
This post only links within verywellhealth.com.
Elsewhere on verywellhealth.com (31)
verywellhealth.com
verywellhealth.com
verywellhealth.com
verywellhealth.com
verywellhealth.com
verywellhealth.com
verywellhealth.com
verywellhealth.com
verywellhealth.com
verywellhealth.com
Similar posts
30 Sept 2026
Radiation omission in patients with clinically node-negative breast cancer undergoing lumpectomy (ROSALIE).
$whoami : echo “tp53(ashish), ml + {medicine, biology} tinkerer” - tp53(ashish)’s home on the interwebs
30 Sept 2026
Eliminating breast surgery for triple negative or HR-/HER2+ breast cancer patients with clinical complete response to combined neoadjuvant chemotherapy and neoadjuvant radiotherapy: A multicenter, phase 2 trial (EBCS).
$whoami : echo “tp53(ashish), ml + {medicine, biology} tinkerer” - tp53(ashish)’s home on the interwebs
30 Sept 2026
A phase III randomized trial of radiotherapy optimization for low-risk HER2-positive breast cancer (HERO): NRG-BR008.
$whoami : echo “tp53(ashish), ml + {medicine, biology} tinkerer” - tp53(ashish)’s home on the interwebs
30 Sept 2026
A randomized trial of trastuzumab deruxtecan and biology-driven selection of neoadjuvant treatment for HER2-positive breast cancer (ARIADNE).
$whoami : echo “tp53(ashish), ml + {medicine, biology} tinkerer” - tp53(ashish)’s home on the interwebs
30 Sept 2026
MELODY: A prospective non-interventional multicenter cohort study to evaluate different imaging-guided methods for localization of malignant breast lesions (EUBREAST-4/iBRA-NET/AGO-B-062, NCT 05559411).
$whoami : echo “tp53(ashish), ml + {medicine, biology} tinkerer” - tp53(ashish)’s home on the interwebs
30 Sept 2026
Something wrong here? Report a problem